3//SEC Filing
Hanmi Pharmaceutical Co., Ltd. 3
Accession 0000899140-25-000440
CIK 0000882361other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:54 PM ET
Size
5.6 KB
Accession
0000899140-25-000440
Insider Transaction Report
Form 3
Hanmi Pharmaceutical Co., Ltd.
10% Owner
Holdings
- 508,710
Common Shares
Warrants to Purchase Common Shares
Exercise: $51.30From: 2024-01-31Exp: 2029-01-31→ Common Shares (77,972 underlying)
Footnotes (2)
- [F1]The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
- [F2]Represents the exercise price per Common Share of the Issuer issuable upon the exercise of the Warrants, as adjusted following the Issuer's 30-to-1 reverse stock split.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001904921
Filing Metadata
- Form type
- 3
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 8:54 PM ET
- Size
- 5.6 KB